Table 7 Distribution of VF genes in relation to fluoroquinolone resistance status and ESBL among E. coli ST131 clinical isolates from women, men and children
VF genesb | Number (%) of isolates with trait by source and ST131 status | P value by isolate source (ESBL vs. non-ESBL)a | ||||
|---|---|---|---|---|---|---|
FQ-R (n = 142) | FQ-S (n = 131 | |||||
ESBL (n = 105) | Non-ESBL (n = 37) | ESBL (n = 53) | Non-ESBL (n = 78) | FQ-R | FQ-S | |
afa/draBC | 13 (12) | 14 (38) | 10 (19) | 31 (40) |  < 0.001 |  < 0.001 |
bmaE | 2 (2) | 0 (0) | 0 (0) | 0 (0) | NS | ns |
sfaS | 17 (16) | 13 (36) | 10 (19) | 31 (40) |  < 0.001 | 0.004 |
fimH | 105 (100) | 37 (100) | 53 (100) | 78 (100) | NS | NS |
focG | 85 (81) | 22 (59) | 31 (58) | 33 (42) | 0.003 | 0.023 |
papGI | 2 (2) | 0 (0) | 0 (0) | 0 (0) | NS | NS |
papGII | 70 (67) | 22 (59) | 15 (29) | 13 (16) | 0.032 | < 0.001 |
papGIII | 60 (57) | 15 (41) | 9 (17) | 16 (20) | 0.04 | NS |
papAH | 76 (72) | 12 (32) | 17 (32) | 26 (33) | < 0.001 | NS |
papC | 72 (69) | 19 (50) | 19 (35) | 30 (38) | 0.003 | NS |
papEF | 82 (78) | 22 (59) | 15 (29) | 31 (40) | < 0.001 | < 0.001 |
gafD | 2 (2) | 0 (0) | 0 (0) | 0 (0) | NS | NS |
cnf1 | 70 (67) | 20 (55) | 28 (52) | 30 (38) | 0.002 | < 0.001 |
hlyA | 76 (72) | 15 (41) | 22 (42) | 23 (29) | < 0.001 | < 0.001 |
iutA | 105 (100) | 37 (100) | 53 (100) | 78 (100) | NS | NS |
fyuA | 105 (100) | 37 (100) | 53 (100) | 78 (100) | NS | NS |
iroN | 18 (17) | 7 (18) | 7 (13) | 3 (4) | NS | 0.031 |
kpsMTII | 105 (100) | 37 (100) | 53 (100) | 78 (100) | NS | NS |
kpsMTIII | 2 (2) | 0 (0) | 0 (0) | 0 (0) | NS | NS |
traT | 105 (100) | 22 (100) | 53 (100) | 78 (100) | NS | NS |
ompT | 105 (100) | 22 (100) | 53 (100) | 78 (100) | NS | NS |
usp | 105 (100) | 22 (100) | 53 (100) | 78 (100) | NS | NS |